Pharmacokinetic Properties and Human Use Characteristics of an FDA-Approved Intranasal Naloxone Product for the Treatment of Opioid Overdose (Q44336921)
scientific article
Language:
(P31) (Q13442814)
(P304) 1243-1253
(P433) 10
(P478) 56
(P577) Thursday, May 5, 2016
(P921) (Q427523)
(Q323936)
(P1433) (Q7743562)
(P1476) "Pharmacokinetic Properties and Human Use Characteristics of an FDA-Approved Intranasal Naloxone Product for the Treatment of Opioid Overdose" (language: en)
(P2093) Philip Krieter
Nora Chiang
Shwe Gyaw
Phil Skolnick
Roger Crystal
Fintan Keegan
Julie Aker
Melissa Beck
Jennifer Harris
(P2860) (Q41583893)
(Q40154815)
(Q26772149)
(Q44337353)
(Q37084008)
(Q36890018)
(Q35135608)
(Q44336009)
(Q38192885)
(Q45422405)
(Q30654725)
(Q52069368)
(Q51774739)
(Q37998744)
(Q45753417)
(Q36891449)
(Q38214338)
(Q35639177)
(Q51007177)
(Q28369955)
(Q34737242)
(Q45122085)
(Q34994071)
(Q44349242)
other details
description scientific article

External Links